Age Of Onset Of Allergic Disease
Background
Allergic diseases, encompassing conditions like asthma, eczema, and food allergies, are complex disorders driven by an overreactive immune response to common environmental substances. The age at which these diseases first appear, known as the age of onset, is a critical characteristic influencing their presentation, course, and overall impact. A deeper understanding of the factors that determine the age of onset can offer valuable insights into disease mechanisms and help distinguish between different manifestations of allergic conditions. Age is recognized as a significant factor influencing the association between genetic predispositions and disease development. [1]
Biological Basis
The development of allergic diseases is shaped by a combination of an individual's genetic makeup and their environmental exposures. Genetic variations can significantly influence the immune system's sensitivity and reactivity, thereby modulating the timing of initial allergic symptoms. For example, the _Gab2_ gene has been identified as playing an essential role in the allergic response. [2] Variations in such genes can affect when immune system dysregulation occurs, leading to an earlier or later onset of allergic symptoms. The intricate interplay between genetic factors and environmental influences is crucial for explaining the development of complex diseases. [3]
Clinical Relevance
The age of onset of allergic disease carries substantial clinical relevance for diagnosis, prognosis, and the formulation of treatment strategies. Early-onset allergies, particularly those appearing in childhood, often follow a characteristic progression, sometimes termed the "allergic march," where conditions like eczema may precede the development of food allergies and then asthma. Identifying genetic markers or environmental factors linked to early or late onset can aid in predicting the disease's trajectory and in tailoring personalized interventions. For instance, a young age of onset for certain conditions can be associated with a stronger family history. [4] The study of age of onset as a quantitative trait or multivariate phenotype is a common approach in genetic analyses of complex diseases. [5]
Social Importance
Allergic diseases impose a considerable burden on affected individuals, their families, and public healthcare systems. The timing of disease onset can profoundly influence a child's development, educational experiences, and overall quality of life, as well as an adult's productivity. Early and accurate identification of individuals at risk for severe or persistent allergies, partly based on their potential age of onset, could facilitate preventive measures and targeted public health initiatives. Such efforts have the potential to significantly reduce the broader societal impact of these widespread conditions.
Methodological and Statistical Constraints
Research into complex traits like age of onset often faces limitations due to sample size, which can restrict the statistical power to detect genetic associations, especially for variants with moderate or small effect sizes. [6] Initial genome-wide association studies (GWAS) may have limited power, with some studies calculating only approximately 50% power to detect an odds ratio of 2.0. [7] This constraint can lead to an inflation of effect-size estimates in discovery phases, making subsequent replication efforts challenging and requiring comparably large sample sizes to confirm findings reliably. [8] Consequently, drawing negative conclusions from inadequately powered replication attempts should be done with caution.
The accuracy of genetic studies is heavily dependent on rigorous quality control measures to minimize genotyping errors and spurious associations. [7] Balancing the stringency of SNP exclusion criteria is critical; overly strict filtering may discard true signals, while overly lenient approaches risk swamping genuine findings with artifacts from poor genotype calling. [9] For instance, single nucleotide polymorphisms (SNPs) deviating significantly from Hardy-Weinberg equilibrium (HWE) are often excluded, though some deviations might be legitimate or attributable to specific genotyping errors, influencing how different statistical models are applied. [10] Staged study designs are sometimes employed to manage multiple comparison corrections, aiming to detect moderate effect sizes without being overly conservative. [7]
Phenotypic Definition and Heterogeneity
Defining and consistently measuring the age of onset of allergic disease presents a significant challenge, as the phenotype is often determined clinically, which can introduce variability. [7] The reliance on clinical definitions means that the precise timing of onset might be subject to recall bias or diagnostic delays, affecting the accuracy and uniformity of the age of onset variable across different study cohorts. [10] Such measurement inconsistencies can dilute genetic signals or lead to heterogeneous findings that are difficult to interpret or generalize.
Allergic diseases encompass a broad spectrum of conditions, and their presentation and underlying mechanisms can vary significantly with age. [4] For example, pediatric-onset inflammatory bowel disease exhibits unique characteristics in phenotype, severity, and family history compared to adult-onset forms, suggesting different genetic or environmental drivers. [4] This phenotypic heterogeneity necessitates careful stratification by age of onset to uncover distinct genetic associations that might otherwise be masked when analyzing broad age ranges, thereby improving the ability to identify specific susceptibility loci.
Population Diversity and Environmental Influences
A common limitation in genetic studies is the restricted ancestral diversity of study cohorts, with many analyses primarily focusing on populations of European descent. [6] While researchers often adjust for population stratification to prevent spurious associations [11] findings from ethnically homogeneous cohorts may not be directly generalizable to other populations due to differences in allele frequencies, linkage disequilibrium patterns, or environmental exposures. This limits the broader applicability of identified risk loci across diverse global populations.
The development and age of onset of allergic diseases are complex traits influenced by a combination of genetic predispositions and environmental factors. [3] Environmental exposures can act as significant confounders, potentially obscuring or modifying genetic signals, making it challenging to disentangle the precise contributions of genes alone. [4] The intricate interplay of gene-environment interactions means that some susceptibility effects may remain uncovered, contributing to the "missing heritability" and indicating a continuing need for comprehensive studies that integrate both genetic and detailed environmental data.
Variants
Genetic variations play a significant role in shaping human development, influencing a wide array of complex traits including growth patterns, pubertal timing, and susceptibility to various diseases. Studies have identified numerous single nucleotide polymorphisms (SNPs) that contribute to the variability observed in these characteristics across populations. For instance, a comprehensive analysis of pubertal growth identified 23 SNPs significantly associated with both height and body mass index (BMI) throughout different stages of puberty. [12] These genetic markers often reside within or near genes that regulate key biological processes, such as hormone production, growth factor signaling, and cellular metabolism, thereby modulating the timing and progression of developmental milestones. The interplay of these genetic factors can influence the age at which individuals experience significant growth spurts and reach sexual maturity, impacting overall health trajectories.
One specific variant, rs8034191, has been investigated for its association with chronic obstructive pulmonary disease (COPD). This SNP is located in a genomic region that may influence lung function and susceptibility to environmental stressors, particularly smoking. While the exact mechanism by which rs8034191 impacts COPD risk is complex, it is understood that variations in such genes can alter cellular responses to damage and inflammation in the lungs, contributing to the development and progression of the disease. [13] Research has indicated that there is no significant direct association between rs8034191 and the amount of smoking (measured as pack-years), suggesting that its effect on COPD risk is not solely mediated through smoking intensity but may involve genotype-by-environment interactions. [13] Such interactions mean that the genetic predisposition conferred by rs8034191 could modify an individual's susceptibility to environmental factors, influencing the age of onset and severity of lung conditions.
Beyond specific disease susceptibility, genetic variants profoundly influence developmental timing, such as the age of menarche in females and the broader pubertal growth period. Genetic risk factors for earlier menarche, for example, have also been shown to influence peri-pubertal body mass index, highlighting the interconnectedness of genetic pathways affecting growth and maturation. [14] Genes involved in these processes often regulate the hypothalamic-pituitary-gonadal axis, a central hormonal pathway controlling reproductive development, and variations can lead to earlier or later onset of puberty. The combined effect of these genetic predispositions and environmental factors ultimately determines an individual's developmental timeline, which can have downstream implications for metabolic health and disease risk later in life. [12]
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| chr1:152307547 | N/A | age of onset of allergic disease contact dermatitis |
Defining Age of Onset
The "age of onset" for a disease refers to the time point when the first discernible symptoms or diagnostic criteria are met. This definition can vary significantly depending on the disease and research context. For instance, in Attention Deficit Hyperactivity Disorder (ADHD), age of onset is often operationalized as the year parents first observe symptoms, which may precede a formal clinical diagnosis. [15] Similarly, for conditions like Alzheimer's disease, the age of onset variable can be statistically constructed using methods such as the Wilcoxon approach, reflecting a more analytical determination rather than a single observable event. [5] This distinction is crucial for understanding disease progression and for genetic studies that seek to identify risk factors associated with early or late presentation.
Classification and Subtypes by Age
Age of onset serves as a critical criterion for classifying disease subtypes and stratifying patient populations, influencing both research and clinical approaches. Studies on inflammatory bowel disease (IBD), for example, explicitly stratify cases by age of onset, recognizing that childhood-onset IBD presents with unique phenotypic characteristics, severity, and familial patterns compared to adult-onset forms. [4] This categorization is also evident in terms such like "early-onset" for myocardial infarction or obesity, which delineate subgroups based on a younger age threshold for disease manifestation. [16] For Type 1 Diabetes, a diagnostic age below 17 years combined with insulin dependence defines a specific pediatric-onset group, allowing for focused investigation into age-specific genetic predispositions or environmental influences. [9]
Terminology and Diagnostic Criteria
The terminology surrounding disease timing includes "age of onset," "age at onset," and "time to onset," all referring to the initiation of the disease process. [5] An alternative, "age of diagnosis," pinpoints the moment clinical criteria are definitively met, as seen in Type 1 Diabetes research where it's a key inclusion criterion. [9] Diagnostic criteria often involve specific thresholds or cut-off values for age. For instance, an "age of diagnosis below 17 years" is a precise criterion used to define pediatric Type 1 Diabetes cohorts, excluding other forms of diabetes through standard clinical evaluation. [9] These standardized criteria ensure consistency in patient selection for research, enabling more accurate identification of genetic associations relevant to particular age groups or disease trajectories.
Causes
The age of onset for allergic disease, a complex trait, is influenced by a confluence of genetic predispositions, developmental factors, environmental exposures, and broader physiological contexts. Research into the age of onset of various complex and immune-mediated conditions provides insights into the mechanisms that likely govern the timing of allergic disease manifestation.
Genetic Predisposition and Inheritance
An individual's genetic architecture plays a foundational role in determining the age at which allergic diseases first manifest. Genome-wide association studies (GWAS) have been instrumental in identifying numerous inherited genetic variants that contribute to the susceptibility and timing of onset for various complex conditions . Genetic factors play a significant role in disease development, as evidenced by familial aggregation and increased concordance in monozygotic twins compared to dizygotic pairs. [17] Variations in gene expression patterns, potentially reflecting underlying genetic differences, may influence an individual's susceptibility and the course of immune-mediated conditions. [7] Regulatory variations, such as those impacting the IL2 gene, are crucial in the pathogenesis of autoimmune diseases, highlighting the importance of genetic control over immune pathways. [9]
Specific genetic loci have been associated with the age of onset in various conditions, with some signals being more pronounced in pediatric cases, suggesting distinct genetic contributions to early-onset phenotypes. [4] For instance, studies have identified candidate genes like SLC9A9, ARRB2, and CHRNA4 that show nominally significant associations with the age of onset of symptoms. [15] Furthermore, genes involved in central nervous system development, organ morphogenesis, and embryonic development have been identified as relevant biological processes linked to age of onset in other complex diseases. [18] The NELL1 gene, for example, has been shown to have tissue-specific expression patterns, and associations with disease have been found with various small linkage disequilibrium blocks within this gene, suggesting multiple causal variants may influence its function. [19]
Immune System Dysregulation and Cellular Pathways
Immune responses are orchestrated by complex molecular and cellular pathways involving critical proteins, enzymes, and receptors. For example, antigen-presenting cells play a vital role in initiating immune responses by presenting specific epitopes to T cells. [20] Dysregulation of these processes can lead to inappropriate and overactive immune responses that mediate tissue damage, as observed in chronic inflammatory disorders. [17] Genes within the Major Histocompatibility Complex (HLA) region, such as HLA-A, HLA-B, HLA-G, HLA-DPB1, HLA-DQA2, and HLA-DQB1, are central to antigen presentation and immune recognition, and variants in these genes are strongly implicated in the susceptibility to immune-mediated diseases. [18]
Key biomolecules involved in immune signaling include CD69, an early T-cell activation antigen, and members of the C-type lectin domain family (CLEC) genes, which are involved in immune cell function and recognition. [9] Additionally, sialic acid-binding immunoglobulin-like lectins (Siglecs) are known to regulate innate immune responses by modulating the lifespan of granulocytes, a class of immune cells critical in inflammatory reactions. [5] These intricate cellular functions and regulatory networks contribute to the overall immune homeostasis, and their disruption can impact the onset and progression of immune-related conditions. [18]
Inflammatory Responses and Tissue Homeostasis
Many conditions, including allergic diseases, are characterized by chronic, relapsing inflammatory processes that disrupt normal tissue homeostasis. An inappropriate and ongoing mucosal immune response can lead to intestinal tissue damage, illustrating how immune dysregulation at the tissue level manifests as disease. [17] The severity and specific characteristics of these inflammatory processes can vary significantly depending on the age of onset, with childhood-onset forms of certain diseases exhibiting unique phenotypes, greater severity, and stronger familial histories. [4] For example, Kawasaki disease, an acute inflammatory condition primarily affecting young children, involves systemic consequences such as fever, rash, and changes to mucous membranes. [7]
The impact of immune responses extends beyond localized effects, leading to systemic consequences that affect multiple organ systems. The interplay between various tissues and organs, mediated by circulating immune cells and inflammatory mediators, is crucial in determining the overall disease phenotype. Disruptions in homeostatic mechanisms, influenced by genetic susceptibility, can trigger compensatory responses that may either mitigate or exacerbate the inflammatory processes, influencing how early symptoms appear and how severe the disease becomes. [17]
Core Signaling Pathways in Allergic Responses
The initiation and progression of allergic diseases are intricately linked to specific intracellular signaling cascades, which dictate the cellular responses to allergens. A crucial component in these pathways is the scaffolding protein Gab2, which plays an essential role in mediating allergic responses. [2] Upon activation of specific receptors, such as IgE receptors on mast cells, Gab2 becomes phosphorylated and acts as a central hub, recruiting and activating downstream signaling molecules. This engagement orchestrates a complex intracellular signaling cascade, ultimately leading to the activation of transcription factors that regulate the expression of genes involved in inflammation and allergic mediator release. The precise regulation and potential dysregulation of Gab2-dependent signaling pathways can thus critically influence the timing and severity of allergic disease onset.
Genetic and Regulatory Influences on Disease Timing
The age at which allergic disease manifests is significantly influenced by an individual's genetic makeup and various regulatory mechanisms. Genetic variations, such as single nucleotide polymorphisms (SNPs), can modulate gene expression or protein function, thereby affecting the timing of pathological processes. For instance, studies on other complex disorders, such as Attention Deficit Hyperactivity Disorder (ADHD) and Alzheimer's disease, have highlighted specific SNPs associated with the age of onset, indicating a genetic predisposition to earlier or later disease manifestation. [15] Similarly, regulatory variations within genes, such as the IL2 gene, which is a major non-MHS locus in Type 1 Diabetes, demonstrate how genetic differences can alter immune pathway activity and contribute to disease timing. [9] These mechanisms underscore how inherited genetic factors modulate the cellular environment and immune reactivity, setting the stage for when allergic responses may first emerge.
Immune System Modulation and Inflammatory Mechanisms
The immune system plays a central role in allergic disease, with its intricate regulatory mechanisms influencing the age of onset. Pathways involving immune cell activation and inflammatory responses are particularly critical. For example, the IL2 pathway is of primary importance in autoimmune diseases [9] and its dysregulation could similarly impact allergic conditions by altering T-cell function and immune tolerance. Furthermore, genes on chromosome 12p13, including CD69 (an early T-cell activation antigen) and several C-type lectin domain family (CLEC) genes, are implicated in immune regulation and could influence the threshold for developing allergic reactions. [9] Additionally, Sialic acid binding immunoglobulin-like lectins (Siglecs) regulate innate immune responses by modulating the lifespan of granulocytes, key effector cells in allergic inflammation, thereby potentially influencing the chronicity and onset of allergic symptoms. [21]
Integrated Network Dynamics and Emergent Onset
The age of onset of allergic disease is an emergent property resulting from the systems-level integration of multiple interacting pathways and their crosstalk. It is not determined by a single genetic factor or environmental trigger but rather by the complex interplay between inherited predispositions, environmental exposures, and the dynamic regulation of cellular responses. For instance, genetic associations with age of onset observed in inflammatory bowel disease (IBD) through genes like IL23R [17] illustrate how specific genetic variants within key immune pathways can influence the timing of disease manifestation. The intricate network interactions between signaling cascades (like Gab2 pathways), gene regulatory mechanisms (affecting IL2 or CLEC expression), and metabolic states collectively shape the immunological landscape. This hierarchical regulation across molecular, cellular, and systemic levels ultimately dictates the susceptibility and the specific age at which an individual develops symptomatic allergic disease.
Genetic Influences and Phenotypic Definition
Genetic factors play a significant role in shaping disease phenotypes, including the timing of disease onset. For instance, the gene Gab2 has been identified as having an essential role in the allergic response. [2] Research into other conditions highlights the utility of "age at first symptoms" as a genetically relevant phenotype. For example, the heritability of the age at onset of Attention Deficit Hyperactivity Disorder (ADHD) has been estimated, suggesting its genetic relevance and informing genetic association studies. [15] This approach allows for the identification of genetic loci where specific genotypes are linked to earlier disease manifestation, potentially indicating distinct underlying biological pathways. [15]
Risk Stratification and Disease Heterogeneity
Stratifying patient populations by age of onset can reveal distinct disease characteristics, enabling better risk assessment and personalized approaches. In inflammatory bowel disease (IBD), for example, childhood-onset IBD presents unique characteristics in phenotype, severity, and family history compared to adult-onset cases. [4] This distinction justifies conducting genome-wide association studies (GWAS) specifically in pediatric cohorts, as it can uncover genetic signals that might be more apparent in younger individuals and could be missed in broader adult studies where environmental factors might obscure genetic associations. [4] Such stratification is crucial for identifying high-risk individuals and understanding the heterogeneous nature of complex diseases.
Prognostic Indicators and Clinical Management
The age of onset can serve as a valuable prognostic indicator, guiding clinical management and predicting long-term implications. Studies on conditions like myocardial infarction have utilized "early-onset" as a specific phenotype in genome-wide association studies to identify susceptibility loci. [22] Similarly, research into Alzheimer's disease has explored the effects of age, sex, and ethnicity on the association between genetic predispositions, such as the apolipoprotein E genotype, and disease development. [1] These examples demonstrate how understanding the age of onset can refine disease prognoses and inform more targeted diagnostic and therapeutic strategies, potentially leading to improved patient care through personalized medicine approaches.
Frequently Asked Questions About Age Of Onset Of Allergic Disease
These questions address the most important and specific aspects of age of onset of allergic disease based on current genetic research.
1. My family has lots of allergies; will my kids get them young?
Yes, there's often a link. If allergies run strongly in your family, especially early-onset forms, your children might have a higher chance of developing them at a younger age due to shared genetic predispositions. Your genes significantly influence the timing of immune system reactivity.
2. Why did my allergies suddenly appear as an adult?
It's a complex mix of your genes and environment. Even with a genetic predisposition, specific environmental triggers or life changes can interact with your genetic makeup, causing allergic symptoms to manifest later in life rather than during childhood.
3. My baby has eczema; does that mean asthma is next?
Not necessarily for every child, but there's a recognized pattern called the "allergic march." For many children, early-onset eczema can indeed precede the development of other allergic conditions like food allergies and then asthma.
4. Can doctors predict when my child's allergies might start?
Researchers are working on it! They are actively looking for specific genetic markers and environmental factors that could help predict the likely age of onset and progression of allergic diseases. This research aims to offer more personalized predictions in the future.
5. Do allergies starting young mean they'll be more severe?
Not always more severe, but early onset can significantly impact a child's development, education, and quality of life. Identifying allergies early is crucial for managing their trajectory and implementing preventive measures to improve long-term outcomes.
6. Can I prevent my child's allergies even with family genes?
While genetics create a predisposition, environmental factors play a huge role. Managing your child's exposures to common allergens and certain environmental influences can significantly impact whether and when allergies appear, even if there's a genetic tendency.
7. Does my family's ethnic background affect my allergy onset?
Yes, it can. Genetic risk factors, how common certain genetic variations are, and typical environmental exposures can differ significantly across various ethnic populations. These differences can influence when allergic diseases are likely to manifest.
8. My sibling got allergies young, but I didn't; why the difference?
Even within the same family, individual genetic variations and unique environmental exposures can lead to different outcomes. The intricate interplay between your specific genes and your personal environment can determine whether and when allergies develop.
9. Why is it so hard to pinpoint exactly when allergies start?
It's challenging because "onset" is often defined clinically, relying on symptoms or diagnosis, which can be subjective or delayed. Also, allergic diseases are very diverse, and different types might have distinct triggers and underlying mechanisms that influence their timing.
10. Can my daily habits influence when my allergies appear?
Yes, your daily habits expose you to various environmental factors that interact with your genetic predispositions. This interplay between your lifestyle and your genes can influence the timing and development of allergic symptoms, either earlier or later in life.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Farrer, L. A., et al. "Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A metaanalysis." JAMA, vol. 278, 1997, pp. 1349-1356.
[2] Gu, H, et al. "Essential role for Gab2 in the allergic response." Nature, vol. 412, 2001, pp. 186–190.
[3] Gatz, M., et al. "Role of genes and environments for explaining Alzheimer disease." Arch Gen Psychiatry, vol. 63, 2006, pp. 168-174.
[4] Kugathasan, S, et al. "Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease." Nat Genet, 2008, PMID: 18758464.
[5] Bertram, L. et al. "Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE." Am J Hum Genet, 2008.
[6] Barrett, J. C. et al. "Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease." Nat Genet, vol. 40, no. 8, 2008, pp. 955-62.
[7] Burgner, D. et al. "A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease." PLoS Genet, vol. 5, no. 1, 2009, p. e1000319.
[8] Abraham, R., et al. "A genome-wide association study for late-onset Alzheimer's disease using DNA pooling." BMC Medical Genomics, vol. 1, 2008, p. 44.
[9] Wellcome Trust Case Control Consortium. "Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls." Nature, 2007.
[10] Beecham, G. W., et al. "Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease." American Journal of Human Genetics, vol. 84, no. 1, 2009, pp. 38-45.
[11] Carrasquillo, M. M., et al. "Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease." Nature Genetics, vol. 41, no. 2, 2009, pp. 192-98.
[12] Cousminer DL. Genome-wide association and longitudinal analyses reveal genetic loci linking pubertal height growth, pubertal timing and childhood adiposity. Hum Mol Genet. 2013;22(10):2106-16.
[13] Pillai SG. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet. 2009;5(3):e1000421.
[14] Johnson,W.,Choh,A.C.,Curren,J.,Czerwinski,S.A.,Bellis,C.,Dyer,T.D., Blangero, J., Towne, B. and Demerath, E.W. Genetic risk for earlier menarche also influences peri-pubertal body mass index. Am. J. Phys. Anthropol. 2013;150:10–20.
[15] Lasky-Su, J, et al. "Genome-wide association scan of the time to onset of attention deficit hyperactivity disorder." Am J Med Genet B Neuropsychiatr Genet, 2008, PMID: 18937294.
[16] Hinney, A. et al. "Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants." PLoS One, 2008.
[17] Duerr, Richard H. "A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene." Science, vol. 314, no. 5804, 2006, pp. 1461-1463.
[18] Baranzini, S. E. et al. "Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis." Hum Mol Genet, vol. 18, no. 1, 2009, p. 19010793.
[19] Franke, A. et al. "Systematic association mapping identifies NELL1 as a novel IBD disease gene." PLoS One, vol. 2, no. 8, 2007, p. e791.
[20] Hunt, Karen A. "Newly Identified Genetic Risk Variants for Celiac Disease Related to the Immune Response." Nature Genetics, vol. 39, no. 4, 2007, pp. 520-525.
[21] von Gunten, Stephan, and Hans-Uwe Simon. "Sialic acid binding immunoglobulin-like lectins may regulate innate immune responses by modulating the life span of granulocytes." FASEB Journal, vol. 20, no. 5, 2006, pp. 601–605.
[22] Kathiresan, S, et al. "Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants." Nat Genet, 2009, PMID: 19198609.